WuXi AppTec Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Shanghai, Shanghai and currently employs 39,414 full-time employees. The company went IPO on 2018-05-08. WuXi AppTec Co Ltd is a China-based company principally engaged in the business of new drug research and development and manufacturing services. The firm conducts its business through six segments. The WuXi Chemistry Segment is primarily engaged in providing new drug research, development and manufacturing services. The WuXi Testing Segment is primarily engaged in providing pharmaceuticals, medical devices, and in vitro diagnostic reagents services. The WuXi Biology Segment is primarily engaged in providing drug discovery and research services. The WuXi ATU Segment is primarily engaged in providing customers with integrated medical product process development, manufacturing and testing services. The WuXi DDSU Segment is primarily engaged in providing customers with integrated new drug research and development services. The Other Segment is primarily engaged in administrative services, sales of raw materials and sales of waste materials.
Follow-Up Questions
Who is the CEO of WuXi AppTec Co Ltd?
Dr. Ge Li is the Chairman of the Board of WuXi AppTec Co Ltd, joining the firm since 2017.
What is the price performance of WUXIF stock?
The current price of WUXIF is $14.77, it has decreased 0% in the last trading day.
What are the primary business themes or industries for WuXi AppTec Co Ltd?
WuXi AppTec Co Ltd belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is WuXi AppTec Co Ltd market cap?
WuXi AppTec Co Ltd's current market cap is $7.5B
Is WuXi AppTec Co Ltd a buy, sell, or hold?
According to wall street analysts, 18 analysts have made analyst ratings for WuXi AppTec Co Ltd, including 9 strong buy, 13 buy, 2 hold, 0 sell, and 9 strong sell
